MariMed Inc MRMD

Morningstar Rating
$0.08 −0.00 (1.23%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MRMD is trading at a LOCK|Q!s<n premium.
Price
$0.08
Fair Value
LOCK|!Z>Z^X$
Uncertainty
LOCK|<<y
1-Star Price
LOCK|Z@hL#>
5-Star Price
LOCK|t$qk&%
Economic Moat
LOCK|^SL
Capital Allocation

Trading Information

Previous Close Price
$0.08
Day Range
$0.080.08
52-Week Range
$0.060.19
Bid/Ask
$0.08 / $0.09
Shares Outstanding
403.04M
Market Cap
$31.91M
Volume/Avg
367,396 / 461,667

Key Statistics

Price/Earnings (Normalized)
68.32
Price/Sales
0.19
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
Total Yield

Company Profile

MariMed Inc is a multi-state cannabis operator in the United States dedicated to improving lives every day through its high-quality products. The company develops, owns, and manages seed to sale state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It has created and continues to develop its own brands of cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other top cannabis products, in select domestic markets. Its operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which it operates.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
923

Valuation

Metric
MRMD
Price/Earnings (Normalized)
68.32
Price/Book Value
0.71
Price/Sales
0.19
Price/Cash Flow
Price/Earnings
MRMD

Financial Strength

Metric
MRMD
Quick Ratio
0.28
Current Ratio
0.92
Interest Coverage
−0.30
Quick Ratio
MRMD

Profitability

Metric
MRMD
Return on Assets (Normalized)
−2.38%
Return on Equity (Normalized)
−9.18%
Return on Invested Capital (Normalized)
0.95%
Return on Assets
MRMD

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|%w@By@RLOCK|TTMRC$69B
Teva Pharmaceutical Industries Ltd ADR
TEVA
LOCK|cVq^#F#LOCK|@m^j<$42B
Haleon PLC ADR
HLN
LOCK|$>wsn>qLOCK|>&$$42B
Zoetis Inc Class A
ZTS
LOCK|&sg$dl>LOCK|J<c$31B
Viatris Inc
VTRS
LOCK|<vPg$TrLOCK|X$$19B
Elanco Animal Health Inc
ELAN
LOCK|S%LOCK|gL>$12B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|?>Hng?qLOCK|nx@$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|!$hXs@@LOCK|vhv$6B
Prestige Consumer Healthcare Inc
PBH
LOCK|@D<<rtLOCK|jNwd^$2B
Perrigo Co PLC
PRGO
LOCK|!qt>DTLOCK|hy$2B

Sponsor Center